These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6716396)

  • 21. [Modulation of the receptors during interaction with pharmacologically active substances (review of the literature)].
    Seĭfulla RD
    Farmakol Toksikol; 1976; 39(4):492-500. PubMed ID: 1027576
    [No Abstract]   [Full Text] [Related]  

  • 22. Conformational changes and drug action.
    Burgen AS
    Fed Proc; 1981 Nov; 40(13):2723-8. PubMed ID: 7297703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Individualized drug therapy].
    Aarbakke J
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2794-5. PubMed ID: 11107927
    [No Abstract]   [Full Text] [Related]  

  • 24. Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery.
    Basu SK
    Biochem Pharmacol; 1990 Nov; 40(9):1941-6. PubMed ID: 2242027
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is chirality a key to stereoselective drug action?].
    Cegła M; Duszyńska B
    Postepy Hig Med Dosw; 1990; 44(4-6):279-98. PubMed ID: 2097612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High content pharmacophores from molecular fields: a biologically relevant method for comparing and understanding ligands.
    Cheeseright TJ; Mackey MD; Scoffin RA
    Curr Comput Aided Drug Des; 2011 Sep; 7(3):190-205. PubMed ID: 21726191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.
    Martin YC
    J Med Chem; 1981 Mar; 24(3):229-37. PubMed ID: 7265109
    [No Abstract]   [Full Text] [Related]  

  • 28. On the parabolic relationship between biological activity and hydrophobicity of drugs: transport or protein binding?
    Franke R
    Experientia Suppl; 1976; 23():25-30. PubMed ID: 954940
    [No Abstract]   [Full Text] [Related]  

  • 29. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 30. Wooldridge Memorial lecture. Pharmacology and new drug discoveries--should veterinarians be interested?
    Black J
    Vet Rec; 1984 Nov; 115(18):466-70. PubMed ID: 6506443
    [No Abstract]   [Full Text] [Related]  

  • 31. Three-dimensional molecular modeling and drug design.
    Gund P; Andose JD; Rhodes JB; Smith GM
    Science; 1980 Jun; 208(4451):1425-31. PubMed ID: 6104357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential and limitations of drug targeting: an overview.
    Gardner CR
    Biomaterials; 1985 May; 6(3):153-60. PubMed ID: 3890975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Age dependent changes in organs and the significance for drug therapy].
    Platt D
    Naturwissenschaften; 1983 Jan; 70(1):15-22. PubMed ID: 6843674
    [No Abstract]   [Full Text] [Related]  

  • 34. Principles of agonism: undressing efficacy.
    Schwartz TW; IJzerman AP
    Trends Pharmacol Sci; 1998 Nov; 19(11):433-6. PubMed ID: 9850604
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of hydrogen-bonds in drug binding.
    Wade RC; Goodford PJ
    Prog Clin Biol Res; 1989; 289():433-44. PubMed ID: 2726808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Theoretical studies on interactions between pharmacon models and ionic receptor binding sites (author's transl)].
    Höltje HD
    Arch Pharm (Weinheim); 1978 Jan; 311(1):2-11. PubMed ID: 626563
    [No Abstract]   [Full Text] [Related]  

  • 38. The structure and function of pyruvate kinase.
    Muirhead H; Grant JP; Lawton MA; Midwinter CA; Nocton JC; Stuart DI
    Biochem Soc Trans; 1981 Jun; 9(3):212-3. PubMed ID: 7274544
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantification of receptor interactions using binding methods.
    Lazareno S
    J Recept Signal Transduct Res; 2001; 21(2-3):139-65. PubMed ID: 11757681
    [No Abstract]   [Full Text] [Related]  

  • 40. Minireview: molecular structure and dynamics of drug targets.
    Dahl SG; Sylte I
    Prague Med Rep; 2008; 109(2-3):107-12. PubMed ID: 19548591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.